Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.
PEPTIDE RESEARCH TOPIC
SLU-PP-332
SLU-PP-332 is an experimental small-molecule ERR agonist. Browse receptor biology, exercise-response experiments, metabolic research, and limits of human claims.
TOPIC OVERVIEW
About SLU-PP-332
Identity and names
SLU-PP-332 is a research compound designation. It should not be confused with differently numbered SLU compounds.
Compound type
It is a synthetic small molecule, not a peptide. Its inclusion here reflects research interest rather than a peptide chemical structure.
Mechanism
It activates estrogen-related receptors, or ERRs. These orphan nuclear receptors are distinct from classical estrogen receptors.
Research focus and evidence
Research examines cellular respiration, skeletal-muscle gene programs, and exercise capacity in experimental models. An exercise-like response is not equivalent to all benefits of physical activity.
Regulatory status and limits
Preclinical findings do not establish a human exercise replacement or a clinical weight-management protocol. Human exposure and clinical outcomes need separate evidence.
Topics covered
- ERR versus estrogen receptors
- small-molecule identity
- cellular respiration
- exercise-response models
- translation and safety limits
Common names and related terms: SLU-PP-332, SLU PP 332
RESEARCH SUMMARY
What Is SLU-PP-332?
LAST VERIFIEDOctober 7, 2026
The primary study identified SLU-PP-332 as an ERR agonist and examined muscle-cell respiration and exercise-related outcomes in mice. The results provide a mechanistic research model, not evidence that the compound replaces exercise in people. SLU-PP-332 primary ERR study
Later chemical-optimization research examines which structural features influence ERR activity and drug-like properties. This work emphasizes that the compound remains a research probe whose pharmacology must be characterized rather than assumed from an exercise-mimetic label. SLU-PP-332 chemical optimization study
EVIDENCE PROFILE
SLU-PP-332 Research Evidence
A concise view of registered clinical research, PubMed-indexed literature, evidence stage, and important limitations.
LAST VERIFIEDOctober 7, 2026
Registered records0
Active studies0
Completed studies0
PubMed records10
Compound typeIt is a synthetic small molecule, not a peptide. Its inclusion here reflects research interest rather than a peptide chemical structure.
AliasesSLU-PP-332, SLU PP 332
Evidence stageResearch examines cellular respiration, skeletal-muscle gene programs, and exercise capacity in experimental models. An exercise-like response is not equivalent to all benefits of physical activity.
U.S. regulatory contextPreclinical findings do not establish a human exercise replacement or a clinical weight-management protocol. Human exposure and clinical outcomes need separate evidence.
Selected registered research
No matching intervention record was found in ClinicalTrials.gov during this verification. This does not mean that no research exists.
Selected PubMed records
Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling.
A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
How to interpret this profile
Registry and publication counts describe discoverable records, not proof of effectiveness or safety. Study design, compound identity, population, endpoints, and regulatory context must be reviewed individually.
START HERE
Essential SLU-PP-332 guides
What Is SLU-PP-332? Research on This ERR AgonistWhat is SLU-PP-332? It is an experimental ERR agonist small molecule studied in mice, not a peptide or approved supplement. Here's what research shows.SLU-PP-332 vs MOTS-c: Research Comparison GuideSLU-PP-332 vs MOTS-c: compare mechanisms, research status, and safety of these investigational compounds. Learn why human data is still limited.SLU-PP-332 for Women: Research, Dosing & SafetySLU-PP-332 for women has no approved human dose. Learn what early mouse studies show, why female dosing charts are unreliable, and the safety unknowns.
SLU-PP-332 KNOWLEDGE ARTICLESPage 1 of 2
KNOWLEDGE ARTICLE
↗SLU-PP-332 vs MOTS-c: Research Comparison Guide
SLU-PP-332 vs MOTS-c: compare mechanisms, research status, and safety of these investigational compounds. Learn why human data is still limited.
KNOWLEDGE ARTICLE
↗SLU-PP-332 Oral Dosage Per Day: What Research Shows
SLU-PP-332 oral dosage per day is not established for humans. Learn what preclinical research shows about SLU-PP-332 oral dosing, tablets, and safety.
KNOWLEDGE ARTICLE
↗SLU-PP-332 Benefits: What Research Really Shows
SLU-PP-332 benefits are mostly preclinical: mouse studies show fat loss and endurance gains, but no human trials exist. Here's what the data show.
KNOWLEDGE ARTICLE
↗SLU-PP-332 Injection Dosage: What Research Shows
There is no established SLU-PP-332 injection dosage for humans. Learn what animal studies used, how oral and injectable routes differ, and the safety unknowns.
KNOWLEDGE ARTICLE
↗How to Reconstitute SLU-PP-332: Step-by-Step Guide
How to reconstitute SLU-PP-332 with DMSO: solvent choice, mg/mL math, and why this research compound turns cloudy when water is added to the vial.
KNOWLEDGE ARTICLE
↗SLU-PP-915 vs SLU-PP-332: Key Differences Explained
SLU-PP-915 vs SLU-PP-332: compare these preclinical ERR agonists on potency, pharmacokinetics, selectivity, and why neither is approved for human use.
KNOWLEDGE ARTICLE
↗What Is SLU-PP-332? Research on This ERR Agonist
What is SLU-PP-332? It is an experimental ERR agonist small molecule studied in mice, not a peptide or approved supplement. Here's what research shows.
KNOWLEDGE ARTICLE
↗SLU-PP-332 Side Effects: What Research Shows
SLU-PP-332 side effects reported by researchers include elevated heart rate, liver enzyme changes, and sleep issues. Learn what human evidence actually shows.
KNOWLEDGE ARTICLE
↗SLU-PP-332 vs 5-Amino-1MQ: Key Differences Explained
SLU-PP-332 vs 5-amino-1MQ compared: mechanism, research findings, dosing forms, legal status, and why neither is FDA-approved for human use.
KNOWLEDGE ARTICLE
↗SLU-PP-332 Jay Campbell: Dosage, Benefits & Safety
SLU-PP-332 Jay Campbell coverage explained: what the research shows, dosing debates, side effects, and why this compound remains research-only.
KNOWLEDGE ARTICLE
↗SLU-PP-332 and BAM15: Research Overview
SLU-PP-332 and BAM15 are research-only metabolic compounds with striking mouse data and no human trials. Compare their mechanisms, dosing gaps, and safety.
KNOWLEDGE ARTICLE
↗SLU PP 332 and Methylene Blue: What Research Shows
SLU PP 332 and methylene blue are different compounds with different risks. Compare their evidence, safety, and legal status for buyers in the US.
KNOWLEDGE ARTICLE
↗SLU-PP-332 Mechanism of Action: How It Works
SLU-PP-332 mechanism of action centers on ERRβ/γ activation and mitochondrial remodeling. Learn what studies show and why human data are still lacking.
KNOWLEDGE ARTICLE
↗SLU PP 332 Injection Price: Cost, Vials & Vendors
SLU PP 332 injection price usually falls between $40 and $180 per vial. Learn what drives cost, why purity testing matters, and what to check before buying.
KNOWLEDGE ARTICLE
↗Where to Buy SLU-PP-332: Sourcing Guide for Researchers
Wondering where to buy SLU-PP-332? Compare vials, capsules, and raw powder, learn what a real COA proves, and see typical prices and legal limits.
KNOWLEDGE ARTICLE
↗SLU-PP-332 Best Brand: How to Choose a Trusted Source
Looking for the SLU-PP-332 best brand? Compare vendors, purity claims, third-party testing, and labeling before you buy any research peptide.
KNOWLEDGE ARTICLE
↗SLU-PP-332 Half-Life: What Research Shows
SLU-PP-332 half-life is short in rodent studies—roughly one to two hours—but no human pharmacokinetic data exist. Learn what that means for dosing research.
KNOWLEDGE ARTICLE
↗SLU-PP-332 Tablets: What Research Says About Oral Forms
SLU-PP-332 tablets are an unapproved research chemical, not a human supplement. Learn what the mouse data shows, how oral forms compare, and safety facts.
KNOWLEDGE ARTICLE
↗SLU-PP-332 Human Trials: What the Evidence Shows
No SLU-PP-332 human trials have been published, and all evidence comes from mice. Here's what the research shows and why human safety is still unknown.
KNOWLEDGE ARTICLE
↗SLU-PP-332 Dosage for Men: What Research Shows
No human trials have established a SLU-PP-332 dosage for men. Here's what animal studies used, how it's sold, and why dosing guidance is still unclear.